GILD Financial Facts
Interest expense: -242MProvision for income taxes: 951M
See Full Income Statement
Noncontrolling interest: 492M
Current portion of long-term debt and other obligations, net: 700M
See Full Balance Sheet
Gilead Sciences Inc. (GILD ) Earnings
|
Expand Research on GILD
| Next EPS Date | 7/30/26 | EPS Growth Rate | -428.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +6.2% | Revenue Growth Rate | +4.2% |
| Average % Move 1-Wk after EPS | +3.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/30/26 |
Q226 | N/A | -$6.60 | N/A | N/A | $7.4B | = | N/A | N/A | ||
| 5/7/26 | Q126 | $2.03 | $1.90 | +$0.13 | $7B | $6.91B | = | ![]() | ![]() | Details | |
| 4/23/26 |
Q126 | N/A | $1.90 | N/A | N/A | $6.91B | = | N/A | N/A | ||
| 2/10/26 | Q425 | $1.86 | $1.85 | +$0.01 | $7.93B | $7.68B | = | ![]() | ![]() | Details | |
| 10/30/25 | Q325 | $2.47 | $2.15 | +$0.32 | $7.8B | $7.45B | = | ![]() | ![]() | Details | |
| 8/7/25 | Q225 | $2.01 | $1.96 | +$0.05 | $7.1B | $6.97B | = | ![]() | ![]() | Details | |
| 4/24/25 | Q125 | $1.81 | $1.77 | +$0.04 | $6.67B | $6.78B | = | ![]() | ![]() | Details | |
| 2/11/25 | Q424 | $1.90 | $1.71 | +$0.19 | $7.6B | $7.16B | = | ![]() | ![]() | Details |




